These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8708756)

  • 21. Optimization of the uptake method for estimating renal clearance of 99mTc mercaptoacetyltriglycine.
    Zhao C; Shuke N; Okizaki A; Yamamoto W; Usui K; Kikuchi K; Kaneko S; Yachiku S; Sasajima T; Aburano T
    Nucl Med Commun; 2004 Feb; 25(2):159-66. PubMed ID: 15154706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reappraisal of single-sample and gamma camera methods for determination of the glomerular filtration rate with 99mTc-DTPA.
    Itoh K; Tsushima S; Tsukamoto E; Tamaki N
    Ann Nucl Med; 2000 Jun; 14(3):143-50. PubMed ID: 10921477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
    Taylor A; Corrigan P; Eshima D; Folks R
    J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of 99Tcm-MAG3 clearance using a single blood sample obtained over a continuous time interval.
    Piera C; Ros D; Pavia J; Fuster D; Muxi A
    Nucl Med Commun; 1997 Jan; 18(1):60-5. PubMed ID: 9061703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A theoretical four-compartment model to evaluate separate kidney technetium-99m-MAG3 kinetics in humans.
    Curti G; DeMartini D; Santaniello B; Taddei G; Fresco GF
    Kidney Int; 1998 Dec; 54(6):2029-36. PubMed ID: 9853268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive measurement of renal function with 99mTc-MAG3 gamma-camera renography based on the one-compartment model.
    Oriuchi N; Onishi Y; Kitamura H; Inoue T; Tomaru Y; Higuchi T; Inoue T; Endo K
    Clin Nephrol; 1998 Nov; 50(5):289-94. PubMed ID: 9840316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
    Müller-Suur R; Bois-Svensson I; Mesko L
    J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
    Russell CD; Dubovsky EV
    J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Unilateral effective renal plasma flow measurement using one-compartment analysis of 99mTc-MAG3 and gamma-camera renography].
    Oriuchi N; Tokunaga M; Suzuki H; Inoue T; Ohnishi Y; Inoue T; Endo K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Sep; 55(11):757-62. PubMed ID: 8532508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal ranges of renal physiological parameters for technetium-99m mercaptoacetyltriglycine and the influence of age and sex using a camera-based method.
    Lin WY; Changlai SP; Kao CH
    Urol Int; 1998; 60(1):11-6. PubMed ID: 9519415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
    Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
    J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility of technetium-99m-MAG3 clearance using the Bubeck method.
    Werner E; Blasl C; Reiners C
    J Nucl Med; 1998 Jun; 39(6):1066-9. PubMed ID: 9627345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bayesian 3-compartment model for 99mTc-MAG3 clearance.
    Russell CD
    J Nucl Med; 2003 Aug; 44(8):1357-61. PubMed ID: 12902428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance.
    Piepsz A; Tondeur M; Kinthaert J; Ham HR
    Eur J Nucl Med; 1996 Feb; 23(2):195-8. PubMed ID: 8925855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deadtime correction in measurement of fractional renal accumulation of 99Tcm-MAG3.
    Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Ohtomo K
    Nucl Med Commun; 1999 Mar; 20(3):267-72. PubMed ID: 10093077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of renal transplant survival from early postoperative radioisotope studies.
    Russell CD; Yang H; Gaston RS; Hudson SL; Diethelm AG; Dubovsky EV
    J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.
    Müller-Suur R; Magnusson G; Bois-Svensson I; Jansson B
    Eur J Nucl Med; 1991; 18(1):28-31. PubMed ID: 1826882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dynamic phantom for radionuclide renography.
    Heikkinen JO
    Phys Med Biol; 1999 Mar; 44(3):N39-53. PubMed ID: 10211814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.